Indian Sorafenib Exporters: Complete Supplier Ranking with Market Share — 341 Manufacturers (2026) — TransData Nexus

Q: Who is the largest sorafenib buyer importing from India?

TORRENT PHARMA INC (UNITED STATES) is the largest sorafenib importer from India with a 12.0% market share and import value of $2.0M.

Q: How many sorafenib buyers import from India?

There are 341 active sorafenib buyers importing from India, with a combined import market of $16.6M across 916 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top sorafenib buyers from India?

The top 5 sorafenib buyers — TORRENT PHARMA INC, TORRENT PHARMA INC,, BY THE ORDER OF, ATLANTA MEDICARE CO LTD, SOFTCARE INTERNATIONAL(PVT)LTD — together control 22.7% of total sorafenib import value from India.

Suresh Sormare

Sorafenib

India Pharmaceutical Trade Intelligence

$16.6M203 Suppliers98 CountriesHS 30049049

ExportsIndia → UNITED STATES75.0%India → SAUDI ARABIA6.5%

ImportsGERMANY → India$172.7K ROMANIA → India$33.3K

#1 Buyer: TORRENT PHARMA

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $12.5M through 12 shipments. This represents a market share of 75.0% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• TORRENT PHARMA INC - $2.0M (16.0% of country's total business)

• TORRENT PHARMA INC, - $1.4M (11.5% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $1.0M, indicating premium pricing strategy compared to the market average of $18.2K.

United States is a key market for Sorafenib imports, representing 75.0% of total trade value.

Primary Market

Secondary Market

2Saudi Arabia

Saudi Arabia emerges as the second largest importing country, achieving a total trade value of $1.1M through 0 shipments. This represents a market share of of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Sorafenib buyer market intelligence

1Buyer Segment Analysis

The importers of Sorafenib from India can be categorized into several key segments:

1. Distributors: Entities that purchase Sorafenib in bulk to supply to various healthcare providers. For instance, TORRENT PHARMA INC in the United States, with total imports amounting to $3.43 million, likely operates as a distributor, given its significant purchase volumes.

2. Hospital Groups: Large healthcare institutions procuring Sorafenib directly for patient treatment. While specific hospital groups are not identified in the top buyers, it's common for such entities to engage in direct procurement to ensure a steady supply for oncology departments.

3. Retail Chains: Pharmacy chains that import Sorafenib to dispense to patients. The data does not specify retail chains among the top buyers, suggesting that retail procurement may occur through domestic distributors rather than direct imports.

4. Government Procurement Agencies: Organizations responsible for national healthcare procurement, including entities like UNICEF or national tender boards. The presence of buyers such as HABIB BANK LIMITED in Pakistan, with imports totaling $0.07 million, indicates involvement in government or institutional procurement processes.

5. Re-exporters: Companies that import Sorafenib with the intent to export to other markets. The data does not explicitly identify re-exporters among the top buyers, but this segment plays a role in global pharmaceutical distribution.

6. Contract Manufacturers: Firms that import Sorafenib as an active pharmaceutical ingredient (API) for formulation into finished products. Specific contract manufacturers are not highlighted in the top buyers, suggesting that such activities may be conducted by entities not listed among the leading importers.

Country-Specific Import Regulations

TransData Nexus Sorafenib buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Sorafenib are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Sorafenib is FDA-approved and comply with the Drug Importation Act. This includes submitting prior notice of importation and ensuring adherence to labeling and manufacturing standards.

Estimated Timeline for Registration: The FDA's drug approval process can take several months to over a year, depending on the completeness of the application and compliance with regulatory requirements.

Import Tariff/Duty for HS 30049049: Pharmaceutical products under HS code 30049049 are generally duty-free in the United States.

2. Saudi Arabia:

Regulatory Authority: Saudi Food and Drug Authority (SFDA).

Demand Drivers & Market Opportunity

TransData Nexus Sorafenib buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Sorafenib in importing countries is influenced by several key factors:

1. Disease Prevalence: Sorafenib is primarily used in the treatment of certain types of cancer, including hepatocellular carcinoma and renal cell carcinoma. The prevalence of these cancers in various countries drives the demand for Sorafenib. For example, regions with higher incidences of liver and kidney cancers will have increased demand for effective treatments like Sorafenib.

2. Government Healthcare Programs: National health initiatives that focus on cancer treatment and management contribute to the demand for Sorafenib. Countries with robust public health programs are more likely to procure Sorafenib through government tenders and subsidies, ensuring wider patient access.

3. Universal Health Coverage Expansion: As countries expand their universal health coverage, access to essential medicines, including oncology drugs like Sorafenib, improves. This expansion leads to increased procurement and distribution through both public and private healthcare sectors.

4. WHO Essential Medicines List Procurement: Inclusion of medicines in the WHO Essential Medicines List (EML) influences national procurement decisions. While Sorafenib's inclusion status should be verified with the latest WHO EML, its recognition can lead to increased adoption in national formularies and procurement programs.

5. Tender-Based Purchasing: Many countries utilize tender systems for the procurement of pharmaceuticals. The presence of 341 buyers across 98 countries, as per TransData Nexus data, indicates a competitive market where suppliers participate in tenders to supply Sorafenib, affecting pricing and availability.

In summary, the demand for Sorafenib is driven by disease prevalence, government healthcare initiatives, expansion of health coverage, inclusion in essential medicine lists, and tender-based procurement processes. These factors collectively shape the market opportunities for Sorafenib in various importing countries.

Common Questions — Sorafenib Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest sorafenib buyer importing from India?

Based on import volume and value, TORRENT PHARMA INC (UNITED STATES) leads with $2.0M in imports and a 12.0% market share — the highest of any single sorafenib importer. TORRENT PHARMA INC, (UNITED STATES) and BY THE ORDER OF (CAMEROON) are the next largest buyers.

QHow many companies buy sorafenib from India?

There are 341 active sorafenib buyers importing from India, with a combined market of $16.6M across 916 shipments to 98 countries. The top 5 buyers hold 22.7% of total import value, while the remaining 336 buyers handle the other 77.3%.

QWhich countries import the most sorafenib from India?

The top importing countries for sorafenib from India are United States (75.0%), Saudi Arabia (6.5%), Guatemala (2.7%), France (1.7%), Nicaragua (1.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of sorafenib, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

Buyer Segment Analysis

TransData Nexus Sorafenib buyer market intelligence

1Buyer Segment Analysis

The importers of Sorafenib from India can be categorized into several key segments:

Country-Specific Import Regulations

TransData Nexus Sorafenib buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Sorafenib are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Import Tariff/Duty for HS 30049049: Pharmaceutical products under HS code 30049049 are generally duty-free in the United States.

2. Saudi Arabia:

Regulatory Authority: Saudi Food and Drug Authority (SFDA).

Demand Drivers & Market Opportunity

TransData Nexus Sorafenib buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Sorafenib in importing countries is influenced by several key factors:

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Sorafenib

Sorafenib

Who Buys Sorafenib from India — 341 Importers Behind a $16.6M Market

Top Sorafenib Importers — Ranked by Import Value

Top Sorafenib Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Sorafenib — and from which countries?

Sorafenib — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

2Saudi Arabia

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Sorafenib Buyers & Importers

QWho is the largest sorafenib buyer importing from India?

QHow many companies buy sorafenib from India?

QWhich countries import the most sorafenib from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Guatemala

4France

5Nicaragua

QWhat is the average import order value for sorafenib from India?

Analysis Methodology